Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE).

McEvoy CT, Ballard PL, Ward RM, Rower JE, Wadhawan R, Hudak ML, Weitkamp JH, Harris J, Asselin J, Chapin C, Ballard RA
Pediatr Res. 2020 88 (4): 629-636

PMID: 32006953 · PMCID: PMC7223897 · DOI:10.1038/s41390-020-0792-y

MeSH Terms (16)

Anti-Inflammatory Agents Birth Weight Bronchopulmonary Dysplasia Budesonide Cytokines Dose-Response Relationship, Drug Female Humans Hydrocortisone Infant, Extremely Premature Infant, Newborn Infant, Premature Male Risk Surface-Active Agents Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: